The Ledger

37 million dollars: that is the 2025 operating loss a financially distressed Ohio hospital had racked up when federal antitrust regulators intervened to reroute its sale, a merger that officially closed this week. Adena Health, an independent nonprofit system based in Chillicothe, Ohio, completed its acquisition of Fairfield Medical Center (FMC) in Lancaster, Ohio, on September 1, 2026, folding FMC into a system that now spans five hospitals and more than 250,000 residents across central and southern Ohio. The deal exists only because the Federal Trade Commission (FTC) intervened in a different one: FMC had pursued a sale to OhioHealth, the state’s largest health system, since 2024, but FTC staff investigated that proposed acquisition, found it “risked raising costs and reducing the quality of care for Ohioans,” and encouraged FMC to run a broader sales process instead of the agency signing off. That process drew multiple bidders and produced a June 1, 2026 letter of intent with Adena; FTC Bureau of Competition director Daniel Guarnera said in a September 2, 2026 statement that “this is a win for the Commission, for FMC, and, most importantly for FMC’s patients and employees,” adding “we will stop bad hospital deals.” Neither party disclosed financial terms of the Adena transaction. Confidence: High on the closing date, FTC involvement, and FMC’s financial distress, drawn from the FTC’s own statement and corroborating local reporting. Sources: Statement Regarding Fairfield Medical Center’s Sale to Adena Health, Federal Trade Commission, Adena Health acquires Fairfield Medical Center after antitrust scrutiny, Healthcare Dive, Fairfield Medical Center joins Adena Health after acquisition, NBC4 WCMH-TV.

696 million dollars: that is what a publicly traded healthcare real estate investment trust (REIT) paid this week for eight senior living communities, its second nine-figure senior housing purchase in three days. American Healthcare REIT announced September 3, 2026 the acquisition of eight senior living communities, totaling 867 units, from developer and operator LCB Senior Living, spanning Massachusetts, Connecticut, New Jersey, Pennsylvania, Delaware and Georgia; the properties were all built between 2020 and 2022, and LCB will keep operating seven of the eight, including two transitioning to LCB from their prior operator at closing. The deal gives American Healthcare REIT, based in Irvine, California, its first major footprint in the supply-constrained Northeast senior housing market and follows the REIT’s separate 572 million dollar purchase of six Kensington Senior Living communities two days earlier, pushing its year-to-date investment total past 2 billion dollars. Confidence: High, drawn from the REIT’s own disclosures and corroborating trade coverage. Sources: American Healthcare REIT Buys 8 Senior Communities for $696M, StockTitan, AHR CEO: New Deals With LCB, Kensington ‘Reflect a Single Strategy’ for Growth, Senior Housing News.

8.2 percent: that is how much employers expect health benefit costs per employee to rise in 2027, the steepest projected jump since 2003. Marsh, the insurance brokerage arm of Marsh McLennan, surveyed more than 1,800 US employers over the summer and found they expect total health benefit cost per employee, combining employer and worker contributions, to climb 8.2 percent next year even after planned cost-cutting steps; without those steps, employers said costs would rise 11 percent on average. To blunt the increase, employers plan to raise deductibles (59 percent of respondents), shift more premium cost onto workers (roughly two-thirds of large employers), and tighten or drop coverage of GLP-1 weight-loss drugs; workers already pay roughly 5,300 dollars a year on average in premiums and out-of-pocket costs combined, up 7.9 percent from the prior year. A separate Aon forecast put next year’s employee-spending increase at 7.9 percent, calling it the largest percentage jump in a decade, two major benefits consultancies converging on the same signal in the same week. Confidence: High on the survey figures, drawn from Marsh’s own release. Medium on how much of the projected increase employers ultimately pass to workers, which depends on plan-design decisions still being finalized for 2027 open enrollment. Sources: Employers Expect Health Benefit Costs to Jump 8.2% in 2027, Marsh via Business Wire, Employer and worker health plan costs expected to jump in 2027, CBS News.

55 million dollars: that is the oversubscribed Series D round a Boston-area cardiovascular imaging company just closed, pulling in its fourth publicly traded medtech company as a strategic investor. Elucid, which makes FDA-cleared artificial intelligence (AI) software called Plaque-IQ that analyzes CT scans to quantify high-risk arterial plaque, announced September 2, 2026 it raised 55 million dollars in Series D financing, bringing its total funding to roughly 185 million dollars; new and existing investors included IAG Capital Partners and Elevage Medical Technologies, a platform backed by Patient Square Capital. The company plans to use the capital to commercialize Plaque-IQ and BioIntegrated FFR-CT, a second product still under US Food and Drug Administration (FDA) review that noninvasively estimates blood flow restriction in coronary arteries, a measurement cardiologists have historically needed an invasive catheterization to get. Confidence: High, drawn from the company’s own announcement and corroborating trade coverage. Sources: Elucid Raises $55 Million in Oversubscribed Series D Financing, BioSpace, Elucid Raises $55M to Expand Non-Invasive Cardiovascular Diagnostic Platform, HIT Consultant.

THE DEAL SHEET

Target	Acquirer/Investor	Vertical	Value	Source
Fairfield Medical Center	Adena Health	Nonprofit hospital merger	Terms not disclosed; completed September 1, 2026 after an FTC-driven pivot from a rival OhioHealth bid	FTC statement, Federal Trade Commission
LCB Senior Living portfolio (8 communities)	American Healthcare REIT	Senior housing real estate	696 million dollars; announced September 3, 2026	American Healthcare REIT Buys 8 Senior Communities for $696M, StockTitan
Elucid	IAG Capital Partners, Elevage Medical Technologies (a Patient Square Capital platform), and other investors	Cardiovascular AI diagnostics	55 million dollar Series D (oversubscribed); announced September 2, 2026	Elucid Raises $55 Million in Oversubscribed Series D Financing, BioSpace
First Atlantic Healthcare (20 Maine nursing homes and assisted-living communities)	Links Healthcare	Post-acute and senior housing real estate	Value undisclosed; announced August 27, 2026, pending Maine state approval	First Atlantic to sell 20 Maine nursing homes to Links Healthcare, Bangor Daily News

This run’s scan of FTC and DOJ merger actions and state transaction-review dockets found no new healthcare antitrust complaints or consent orders in the last 24 to 48 hours beyond the Fairfield Medical Center matter above. A frontier check on the clinical trials supply chain, contract research organizations (CROs) and decentralized-trial technology vendors, a Ledger branch not touched in the last three issues, found no new deal or funding announcement dated to this window; the branch’s last dedicated Ledger story ran July 31 on decentralized clinical trial AI funding. An open-ended scan surfaced Marsh’s employer health benefit cost survey, covered above, as the window’s most consequential business signal outside the Deal Sheet.